Core Viewpoint - The inclusion of the HPV vaccine in China's national immunization program marks the first expansion in 18 years, aimed at improving women's health and addressing the rising incidence of cervical cancer among younger populations [2][16]. Group 1: HPV Vaccine Overview - The HPV vaccine is now part of the national immunization program, which previously focused mainly on children under six years old [2][16]. - As of now, there are six approved HPV vaccines in China, including both imported and domestic options [4][10]. - The HPV vaccine is recognized as the most effective method for preventing cervical cancer, which is primarily caused by high-risk HPV types [8][9]. Group 2: Demand and Coverage - Despite a surge in demand for HPV vaccines, the coverage rates remain low, with only 10.15% of eligible women receiving the first dose by 2022 [11][12]. - The high cost of vaccines has been a barrier to access, with imported vaccines priced between 580 to 800 RMB per dose [10][14]. - Public awareness and misconceptions about vaccine safety have also contributed to low uptake rates [15][36]. Group 3: Government Initiatives and Support - The Chinese government is committed to promoting HPV vaccination, aligning with the WHO's goal of eliminating cervical cancer by 2030 [16][28]. - Pilot programs in various cities have successfully increased vaccination rates, demonstrating the effectiveness of government-led initiatives [21][25]. - The national immunization program aims to provide equitable access to vaccines, particularly for underserved populations [34]. Group 4: Economic Considerations - The economic evaluation of HPV vaccination is crucial for justifying its inclusion in the national program, focusing on cost-effectiveness and public health benefits [27][28]. - The reduction in newborn numbers has also created budgetary space for expanding the immunization program [31][32]. - The competition among vaccine suppliers has led to significant price reductions, making vaccines more accessible [30]. Group 5: Future Prospects - The integration of HPV vaccines into the national immunization program is expected to significantly increase vaccination rates, similar to past experiences with other vaccines [37]. - Domestic manufacturers are ramping up production capacity, ensuring a stable supply of vaccines [37]. - Ongoing research and development in HPV vaccines, including the introduction of a nine-valent vaccine, indicate a positive trend in cervical cancer prevention efforts in China [37].

2024年，万泰生物实现营业收入22.45亿元，同比下降59.25%；归属于上市公司股东的净利润1.06亿 元，同比下降91.49%；归属于上市公司股东的扣除非经常性损益的净利润-1.86亿元，上年同期10.78亿 元；经营活动产生的现金流量净额为3.55亿元，同比下降76.91%。 中国经济网北京8月6日讯万泰生物（603392）(603392.SH)近日发布的2025年半年度业绩预亏公告显 示，经财务部门初步测算，预计2025年半年度实现归属于母公司所有者的净利润为-16,000万元 到-13,000万元，与上年同期相比，将出现亏损。预计2025年半年度实现归属于母公司所有者的扣除非 经常性损益的净利润为-26,000万元到-23,000万元。 上年同期，万泰生物实现归属于母公司所有者的净利润26,048万元，归属于母公司所有者的扣除非经常 性损益的净利润6,352万元。 万泰生物首次募集资金总额为3.82亿元，募集资金净额为3.18亿元。万泰生物2020年4月14日发布招股书 显示，募集资金中1.50亿元用于化学发光试剂制造系统自动化技术改造及国际化认证项目，1.50亿元用 于宫颈癌疫苗质量体系提升及国 ...

Core Viewpoint - The article emphasizes the importance of vaccination in disease prevention and health protection, highlighting the distinction between government-provided vaccines and those that are voluntarily chosen by individuals [1][2]. Group 1: Vaccination Importance - Vaccination is described as the most economical and effective means of preventing and controlling diseases, extending from newborns to the elderly [1]. - The vaccination program includes 14 types of immunization vaccines provided for free by the government, aimed at preventing 15 infectious diseases [1]. Group 2: Types of Vaccines - Immunization vaccines are mandatory and free, while non-immunization vaccines are voluntary and self-paid, including flu, pneumonia, and cervical cancer vaccines [1]. - Individuals are encouraged to choose non-immunization vaccines based on personal needs and informed consent [1]. Group 3: Vaccine Safety and Management - The article outlines strict management protocols in China for vaccine development, production, distribution, and administration to ensure traceability [2]. - Common mild reactions to vaccines include fever and local swelling, which typically resolve within 1-3 days, while severe reactions are rare [2]. Group 4: Pre-vaccination Recommendations - It is advised that individuals understand vaccine information and disclose any medical history before vaccination, as well as maintain a healthy state prior to receiving vaccines [2]. - Some vaccination clinics offer services on weekends, allowing the public to schedule appointments via the "Guangxi CDC" WeChat account [2].